|
|
 |
Trial Information
Summary: Research study of an investigational drug for the treatment of Alzheimer's Disease.
Patients with mild-to-moderate Alzheimer's disease may
qualify to participate in a research study of an investigational
drug. Study related evaluations and study drug are provided at no
cost. Qualified participants will receive travel reimbursement up
to $125.00.
|
Contact:
David Ira Margolin, M.D., Ph.D.
The Margolin Brain Institute
1515 E. Alluvial Avenue
Suite 101
Fresno, CA 93720
Telephone: 559-299-1515
Fax: 559-324-1941
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 5:44:02 AM
|
 |
|